Skip to content

Treatment of wart with topical formaline 5% solution

Comparision of efficacy of application formaline 5% solution versus placebo in the treatment of wart: a double-blind and randomized placebo-control clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016031627076N1
Enrollment
56
Registered
2016-05-21
Start date
2015-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wart. viral warts

Interventions

Intervention 1: interventional group: in this group 28 patients treat with topical formaline 5% solution twice a day for 8 cosecutive week. for plane warts the solution applicate on warts by a cotton
Treatment - Drugs
interventional group: in this group 28 patients treat with topical formaline 5% solution twice a day for 8 cosecutive week. for plane warts the solution applicate on warts by a cotton swab for 1 minut
control group: in this group 28 patients treat with topical normal saline solution twice a day for 8 cosecutive week. for plane warts the solution applicate on warts by a cotton swab for 1 minute and

Sponsors

Vice chancellor for research, Ahwaz Jundishapur University of Medical Sciencses
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with wart older than 4 years old whitout any limitations on patients sex; wart number; duration of disease. Exclusion criteria: any treatment simultaneously; hypersensitivity to formaline; immune deficiency; persence of sever dermatitis; persence of inflammation or ulcer in the affected skin; patients with history of asthma or other respiratory diseases; warts wich located on eyelids, around lips and ala of nose.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wart size and count change. Timepoint: Before intervention and then every 2 week during intervention. Method of measurement: By a ruler( size) and counting.

Secondary

MeasureTime frame
Dryness, erythem and fissuring of the skin. Timepoint: Before intervention and then every 2 week during intervention. Method of measurement: questionnare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehri Maghsoodi

Ahwaz Jundishapur University of Medical Scienses

maghsoodi.m@ajums.ac.ir+98 61 3292 1837

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026